Showing results (91-100 of 136) with videos related to
Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinomaJohn A Thompson, Brendan D Curti, Bruce G Redman, et al.British Journal of Haematology|May 27, 2009
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphomaAndres Forero-Torres, John P Leonard, Anas Younes, et al.Leukemia & Lymphoma|June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trialAzra Raza, Joseph G Jurcic, Gail J Roboz, et al.Blood|March 6, 2002
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in childrenAnn E Woolfrey, Claudio Anasetti, Barry Storer, et al.Cell Stem Cell|October 7, 2017
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid NeoplasiaZuzana Tothova, John M Krill-Burger, Katerina D Popova, et al.Blood|November 10, 1998
Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndromeA E Woolfrey, T A Gooley, E L Sievers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupRichard Aplenc, Todd A Alonzo, Robert B Gerbing, et al.Blood|December 24, 2014
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphomaAjay K Gopal, Robert Chen, Scott E Smith, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart StudyB V Howard, D C Robbins, M L Sievers, et al.Mabs|January 13, 2010
Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Timothy S Lewis, et al.Pageof 14